Diabetes and obesity continue to represent major challenges to the health and health care systems of the USA and other countries. Current therapies are helpful, especially for type 2 diabetes, but they are still inadequate to prevent the negative effects of the Metabolic Syndrome on the cardiovascular system, cancer and other disorders. It has long been recognized that exercise is an excellent first line therapy for both diabetes and obesity [1];however, many patients are unable to exercise sufficiently for a variety of reasons. A huge challenge has been to """"""""capture"""""""" some of the benefits of exercise in a manner that can be useful medically for the very broad range of diseases for which exercise appears to provide benefit. Previous work on this grant has shown that the transcriptional coactivator PGC1? is induced with exercise in muscle and gives muscle many of the attributes seen in this tissue with chronic exercise. We show here that PGC1? expression in cultured muscle cells and transgenic mice stimulates the secretion of an activity that can drive the expression of UCP1 and other genes of the brown fat program in white adipose cells. Using global gene expression analyses, coupled with bioinformatics tools, we identify a key secreted protein as Fndc5, a muscle protein previously identified as an intracellular factor. We show here that Fndc 5 is cleaved and secreted as a novel 112 amino acid polypeptide termed irisin. Circulating irisin is increased with exercise in rodents and humans, and mildly elevated irisin in mice stimulates a browning of the white fat, with increased energy expenditure and improved glucose homeostasis.
Aim 1 of this new application proposes purifying and cloning the cellular irisin receptor using an active fusion protein between irisin and the Fc moiety of human IgG. Alternatively, this tool can also be used to isolate the irisin receptor by expression cloning. Critical tests of the function of the irisin receptor will involve genetic manipulations in both cultured cells and in the adipose tissues of mice.
Aim 2 examines the mechanism by which PGC1? controls irisin gene expression. We will employ a cultured muscle cell system to examine the """"""""chromatin marks"""""""" at and near the Fndc5 locus to identify the key transcription factors through which PGC1? activates Fndc5 expression. We will also study whether manipulation of these key PGC1?-docking factors can regulate irisin expression in vivo. Post-translation modifications (PTM) of PGC1? have been shown to be important modulators of its function but there have been no systematic examination of PTMs in any biological system.
In Aim 3 we will purify PGC1? from skeletal muscle under sedentary and exercised conditions. In collaboration with Steven Gygi and Pere Puigserver, we will determine all covalent modifications by quantitative Mass Spectrometry. Mutant alleles will be utilized both in vitro and in vivo to ascertain the physiological significance of these PTMs. Together these studies should lend important insights into the basic science of muscle and exercise as well as open new avenues for the rapid development of new therapeutics.

Public Health Relevance

Diabetes and obesity take a major toll on health in the US. We have found a new polypeptide hormone that is produced by muscle with exercise and we will explore the molecular mechanisms by which this hormone increases energy expenditure and improves abnormalities in glucose homeostasis. This work has exciting promise for the development of new treatments for metabolic diseases and other disorders that are improved with exercise.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Integrative Physiology of Obesity and Diabetes Study Section (IPOD)
Program Officer
Haft, Carol R
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Dana-Farber Cancer Institute
United States
Zip Code
Sylow, Lykke; Long, Jonathan Z; Lokurkar, Isha A et al. (2016) The Cancer Drug Dasatinib Increases PGC-1? in Adipose Tissue but Has Adverse Effects on Glucose Tolerance in Obese Mice. Endocrinology 157:4184-4191
Long, Jonathan Z; Svensson, Katrin J; Bateman, Leslie A et al. (2016) The Secreted Enzyme PM20D1 Regulates Lipidated Amino Acid Uncouplers of Mitochondria. Cell 166:424-435
Liu, Xiaojun; Xiao, Junjie; Zhu, Han et al. (2015) miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell Metab 21:584-95
Jedrychowski, Mark P; Wrann, Christiane D; Paulo, Joao A et al. (2015) Detection and Quantitation of Circulating Human Irisin by Tandem Mass Spectrometry. Cell Metab 22:734-740
Kong, Xingxing; Banks, Alexander; Liu, Tiemin et al. (2014) IRF4 is a key thermogenic transcriptional partner of PGC-1?. Cell 158:69-83
Wu, Jun; Spiegelman, Bruce M (2014) Irisin ERKs the fat. Diabetes 63:381-3
Wrann, Christiane D; White, James P; Salogiannnis, John et al. (2013) Exercise induces hippocampal BDNF through a PGC-1?/FNDC5 pathway. Cell Metab 18:649-59
Kleiner, Sandra; Mepani, Rina J; Laznik, Dina et al. (2012) Development of insulin resistance in mice lacking PGC-1? in adipose tissues. Proc Natl Acad Sci U S A 109:9635-40
Boström, Pontus; Wu, Jun; Jedrychowski, Mark P et al. (2012) A PGC1-?-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481:463-8
Wu, Jun; Ruas, Jorge L; Estall, Jennifer L et al. (2011) The unfolded protein response mediates adaptation to exercise in skeletal muscle through a PGC-1?/ATF6? complex. Cell Metab 13:160-9

Showing the most recent 10 out of 26 publications